Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Summary
A randomized, double-blind, placebo-controlled, multi-center phase III study to compare the efficacy and safety of aprepitant injection and placebo in the prevention of post-operative nausea and vomiting (PONV).,
Official title: A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Aprepitant Injection in the Prevention of Post-operative Nausea and Vomiting
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
486
Start Date
2024-10-28
Completion Date
2026-03-28
Last Updated
2024-08-09
Healthy Volunteers
No
Interventions
Aprepitant Injection
Before anesthesia induction, 4.4ml(32mg） was given by a single intravenous injection, which was completed within 30 seconds
Aprepitant Injection Placebo
Before anesthesia induction, 4.4ml(0mg） was given by a single intravenous injection, which was completed within 30 seconds